Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Irritable Bowel Syndrome, October 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 99 articles:
HTML format


 

Single Articles

  1. EBRAHIMI A, Forghani M, Bababkhanian M, Ebrahimi M, et al
    Psychometric properties of Persian version of irritable bowel syndrome- behavioral responses questionnaire (IBS-BRQ).
    Gastroenterol Hepatol Bed Bench. 2023;16:326-335.
    PubMed    
    Abstract available

  2. CHIARIONI G, Popa SL, Ismaiel A, Pop C, et al
    The Effect of Polyphenols, Minerals, Fibers, and Fruits on Irritable Bowel Syndrome: A Systematic Review.
    Nutrients. 2023;15:4070.
    PubMed    
    Abstract available

  3. QU Y, Park SH, Dallas DC
    The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome.
    Nutrients. 2023;15:3991.
    PubMed    
    Abstract available

  4. DAHIYA D, Nigam PS
    Nutraceutical Combinational Therapy for Diarrhoea Control with Probiotic Beverages from Fermented Fruits, Vegetables and Cereals to Regain Lost Hydration, Nutrition and Gut Microbiota.
    Microorganisms. 2023;11:2190.
    PubMed    
    Abstract available

  5. KOVALEVA A, Poluektova E, Maslennikov R, Karchevskaya A, et al
    Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial.
    J Clin Med. 2023;12:6064.
    PubMed    
    Abstract available

  6. SCIUME GD, Berti G, Lambiase C, Paglianiti I, et al
    Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights.
    J Clin Med. 2023;12:5787.
    PubMed    
    Abstract available

  7. SCHNEDL WJ, Schenk M, Michaelis S, Enko D, et al
    Functional Abdominal Pain Disorders in Children May Be Associated with Food Intolerance/Malabsorption.
    Children (Basel). 2023;10:1444.
    PubMed    
    Abstract available

  8. KINOSHITA Y, Sanuki T
    Review of Non-Eosinophilic Esophagitis-Eosinophilic Gastrointestinal Disease (Non-EoE-EGID) and a Case Series of Twenty-Eight Affected Patients.
    Biomolecules. 2023;13:1417.
    PubMed    
    Abstract available

  9. CHOI EL, Taheri N, Tan E, Matsumoto K, et al
    The Crucial Role of the Interstitial Cells of Cajal in Neurointestinal Diseases.
    Biomolecules. 2023;13:1358.
    PubMed    
    Abstract available

  10. DA SILVA JT, Hernandez-Rojas LG, Mekonen HK, Hanson S, et al
    Sex differences in visceral sensitivity and brain activity in a rat model of comorbid pain: a longitudinal study.
    Pain. 2023 Sep 27. doi: 10.1097/j.pain.0000000000003074.
    PubMed    
    Abstract available

  11. BAUMGARTNER C, Monnier J, Bastid C, Gillabert C, et al
    [Chronic abdominal pain from digestive origin : summary 2023].
    Rev Med Suisse. 2023;19:1743-1747.
    PubMed    
    Abstract available

  12. BOUDABBOUS M, Issa AB, Feki I, Gdoura H, et al
    Alexithymia impairs quality of life in irritable bowel syndrome.
    Future Sci OA. 2023;9:FSO881.
    PubMed    
    Abstract available

  13. AGWA RH, Alharthi Z, Alzahrani AT, Alghamdi MA, et al
    The Prevalence of Irritable Bowel Syndrome and Its Co-existence With Migraine in Medical and Non-medical Students at Al-Baha University, Saudi Arabia.
    Cureus. 2023;15:e44077.
    PubMed    
    Abstract available

  14. MAGDY R, Othman AS, Elsebaie EH, Elsayed RM, et al
    Comorbid conditions in Egyptian patients with migraine.
    Neurol Res. 2023 Sep 25:1-11. doi: 10.1080/01616412.2023.2257418.
    PubMed    
    Abstract available

  15. CHOGLE A, Visnagra K, Janchoi J, Tran T, et al
    Prospective study of the effect of auricular percutaneous electrical nerve field stimulation on quality of life in children with pain related disorders of gut-brain interaction.
    Front Pain Res (Lausanne). 2023;4:1223932.
    PubMed    
    Abstract available

  16. HONG H, Mocci E, Kamp K, Zhu S, et al
    Genetic Variations in TrkB.T1 Isoform and Their Association with Somatic and Psychological Symptoms in Individuals with IBS.
    medRxiv. 2023 Sep 14:2023.09.14.23295434. doi: 10.1101/2023.09.14.23295434.
    PubMed    
    Abstract available

  17. YANG J, Wei Q, Xiang Z, Wu D, et al
    Bowel preparation efficacy and safety of compound polyethylene glycol electrolyte powder combined with linaclotide for colonoscopy: A randomized controlled trial.
    JGH Open. 2023;7:636-639.
    PubMed    
    Abstract available

  18. FAN W, Fang X, Fei G, Li X, et al
    Sera anti-neuronal antibodies in patients with irritable bowel syndrome and their correlations with clinical profiles.
    Neurogastroenterol Motil. 2023 Sep 24:e14682. doi: 10.1111/nmo.14682.
    PubMed    
    Abstract available

  19. BRENNER DM, Ladewski AM, Kinsinger SW
    Development and Current State of Digital Therapeutics for Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2023 Sep 22:S1542-3565(23)00749.
    PubMed    
    Abstract available

  20. ZORINA-LICHTENWALTER K, Ase AR, Verma V, Parra AIM, et al
    Characterisation of common genetic variants in P2RX7 and their contribution to chronic pain conditions.
    J Pain. 2023 Sep 22:S1526-5900(23)00541-2. doi: 10.1016/j.jpain.2023.
    PubMed    
    Abstract available

  21. QIU L, Shen R, Wei L, Xu S, et al
    Designing a microbial fermentation-functionalized alginate microsphere for targeted release of 5-ASA using nano dietary fiber carrier for inflammatory bowel disease treatment.
    J Nanobiotechnology. 2023;21:344.
    PubMed    
    Abstract available

  22. SCHNEDL WJ, Michaelis S, Mangge H, Enko D, et al
    A personalized management approach in disorders of the irritable bowel syndrome spectrum.
    Clin Nutr ESPEN. 2023;57:96-105.
    PubMed    
    Abstract available

  23. LARI A, Shidfar F, Aminianfar A, Keshteli AH, et al
    Dietary intake of phytochemicals in association with irritable bowel syndrome in adults.
    Clin Nutr ESPEN. 2023;57:158-165.
    PubMed    
    Abstract available

  24. WEAVER-TOEDTMAN KR, Walch M, Kiracofe L, Bedingfield A, et al
    Feasibility and Acceptability of an Online Yoga Study Among Individuals with Irritable Bowel Syndrome (IBS).
    Int J Yoga Therap. 2023;33:Article 8.
    PubMed    
    Abstract available

  25. MEHRZADI S, Sheibani M, Koosha F, Alinaghian N, et al
    Protective and therapeutic potential of melatonin against intestinal diseases: updated review of current data based on molecular mechanisms.
    Expert Rev Gastroenterol Hepatol. 2023 Oct 5. doi: 10.1080/17474124.2023.2267439
    PubMed    
    Abstract available

  26. KARTAL B, Sahiner IT
    Red Cell Distribution Width, Mean Platelet Volume, and Neutrophil/Lymphocyte Ratio in Patients With Irritable Bowel Syndrome.
    Cureus. 2023;15:e44496.
    PubMed    
    Abstract available

  27. TERRA I, Santeiro C, da Fonseca Rua J
    Supplementation With Bifidobacterium and Symptomatic Control in Irritable Bowel Syndrome: An Evidence-Based Review.
    Cureus. 2023;15:e44447.
    PubMed    
    Abstract available

  28. HONG H, Schulze KV, Copeland IE, Atyam M, et al
    Genetic Variants in Carbohydrate Digestive Enzyme and Transport Genes Associated with Risk of Irritable Bowel Syndrome.
    medRxiv. 2023 Sep 22:2023.09.20.23295800. doi: 10.1101/2023.09.20.23295800.
    PubMed    
    Abstract available

  29. LU X, Zhang S
    How Tongxie-Yaofang Regulates Intestinal Synaptic Plasticity by Activating Enteric Glial Cells and NGF/TrkA Pathway in Diarrhea-Predominant Irritable Bowel Syndrome Rats.
    Drug Des Devel Ther. 2023;17:2969-2983.
    PubMed    
    Abstract available

  30. LONG YQ, Xu WL, Li LX, He HQ, et al
    Characteristics and risk factors of Functional Dyspepsia fulfilling the Rome IV Criteria overlapping with Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Constipation in South China.
    J Neurogastroenterol Motil. 2023 Sep 27. doi: 10.5056/jnm23084.
    PubMed    
    Abstract available

  31. STORY G, Briere CE, McClements DJ, Sela DA, et al
    Cannabidiol and Intestinal Motility: a Systematic Review.
    Curr Dev Nutr. 2023;7:101972.
    PubMed    
    Abstract available

  32. YUAN Y, Wang X, Huang S, Wang H, et al
    Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships.
    Gut Microbes. 2023;15:2263209.
    PubMed    
    Abstract available

  33. WANG Y, Ma W, Mehta R, Nguyen LH, et al
    Diet and gut microbial associations in irritable bowel syndrome according to disease subtype.
    Gut Microbes. 2023;15:2262130.
    PubMed    
    Abstract available

  34. PATEL PK, Tanpowpong P, Sriaroon P, Lockey RF, et al
    "Non-Allergic Diseases Associated with Foods".
    J Allergy Clin Immunol Pract. 2023 Sep 30:S2213-2198(23)01058.
    PubMed    
    Abstract available

  35. SWAIN SM, Liddle RA
    Mechanosensing Piezo channels in gastrointestinal disorders.
    J Clin Invest. 2023;133:e171955.
    PubMed    
    Abstract available

  36. CHEN J, Sun Y, Fu T, Lu S, et al
    Risk of incident cardiovascular disease among patients with gastrointestinal disorder: a prospective cohort study of 330,751 individuals.
    Eur Heart J Qual Care Clin Outcomes. 2023.
    PubMed    
    Abstract available

  37. GOLD SM, Friede T, Meyer B, Moss-Morris R, et al
    Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial.
    Lancet Digit Health. 2023;5:e668-e678.
    PubMed    
    Abstract available

  38. GARCIA-CABRERA AM, De la Portilla F, Jimenez-Rodriguez RM, Vazquez-Monchul JM, et al
    Efficacy of Sacral Nerve Stimulation in Non-constipated Irritable Bowel Syndrome Patients: A Systematic Review.
    J Gastrointestin Liver Dis. 2023;32:384-392.
    PubMed    
    Abstract available

  39. WANG RH, Lin YK, Xie HK, Li H, et al
    Exploring the synergistic pharmacological mechanism of Huoxiang Drink against irritable bowel syndrome by integrated data mining and network pharmacology.
    Medicine (Baltimore). 2023;102:e35220.
    PubMed    
    Abstract available

  40. ZHANG WX, Shi LB, Zhou MS, Wu J, et al
    Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    J Med Microbiol. 2023;72.
    PubMed    
    Abstract available

  41. CAMILLERI M, BouSaba J
    New Developments in Bile Acid Diarrhea.
    Gastroenterol Hepatol (N Y). 2023;19:520-537.
    PubMed    
    Abstract available

  42. CHOI SI, Kim N, Nam RH, Jang JY, et al
    The Protective Effect of Roseburia faecis Against Repeated Water Avoidance Stress-induced Irritable Bowel Syndrome in a Wister Rat Model.
    J Cancer Prev. 2023;28:93-105.
    PubMed    
    Abstract available

  43. ALHAMMADI NA, Bedywi RM, Shawkhan RA, Aljari AA, et al
    Migraine and Irritable Bowel Syndrome Among the General Population in Aseer Region.
    Cureus. 2023;15:e45047.
    PubMed    
    Abstract available

  44. ASIRI AS, Algarni SS, Althubaiti AQ, Alzubaidi MA, et al
    Fecal Calprotectin and Organic Gastrointestinal Disease: A Systematic Review.
    Cureus. 2023;15:e45019.
    PubMed    
    Abstract available

  45. TOCA MDC, Burgos F, Tabacco O, Vinderola G, et al
    Postbiotics: A new member in the biotics family.
    Arch Argent Pediatr. 2023 Oct 19:e202310168. doi: 10.5546/aap.2023-10168.
    PubMed    
    Abstract available

  46. XUE H, Mei CF, Wang FY, Tang XD, et al
    Relationship among Chinese herb polysaccharide (CHP), gut microbiota, and chronic diarrhea and impact of CHP on chronic diarrhea.
    Food Sci Nutr. 2023;11:5837-5855.
    PubMed    
    Abstract available

  47. BACON RL, Taylor L, Gray SB, Hodo CL, et al
    Analysis of cell populations in the normal rhesus macaque (Macaca mulatta) lower intestinal tract and diagnostic thresholds for chronic enterocolitis.
    Vet Pathol. 2023 Oct 11:3009858231203315. doi: 10.1177/03009858231203315.
    PubMed    
    Abstract available

  48. ASLAN DOGAN L, Gokdemir O, Ozcakar N
    Frequency of Irritable Bowel Syndrome Among Children Aged 4 to 9 Years: A Cross-Sectional Study.
    Clin Pediatr (Phila). 2023 Oct 11:99228231204455. doi: 10.1177/00099228231204455
    PubMed    
    Abstract available

  49. PRILLAMAN G, Zillioux J, Beller H, Yeaman C, et al
    Predictors of pelvic pain in a general urology clinic population.
    BJUI Compass. 2023;4:668-672.
    PubMed    
    Abstract available

  50. SALGADO-DELGADO RC, Espinosa-Tanguma R, Valdes Abadia B, Ramirez-Plascencia OD, et al
    Feeding during the resting phase causes gastrointestinal tract dysfunction and desynchronization of metabolic and neuronal rhythms in rats.
    Neurogastroenterol Motil. 2023 Oct 10:e14687. doi: 10.1111/nmo.14687.
    PubMed    
    Abstract available

  51. ZHANG J, Zhang C, Zhang T, Zhang L, et al
    Distinct Effects of Non-absorbed Agents Rifaximin and Berberine on the Microbiota-Gut-Brain Axis in Dysbiosis-induced Visceral Hypersensitivity in Rats.
    J Neurogastroenterol Motil. 2023;29:520-531.
    PubMed    
    Abstract available

  52. SOMVANAPANICH P, Pitisuttithum P, Sirimongkolkasem J, Rattanachaisit P, et al
    Spot Hydrogen Breath Test for Predicting Response to Low Fermentable Oligo-, Di-, Mono-saccharides, and Polyols Dietary Advice in Patients With Bloating.
    J Neurogastroenterol Motil. 2023;29:513-519.
    PubMed    
    Abstract available

  53. GU Q, Zhang H, Li J, He T, et al
    Effects of PAR2 Gene Knockout on Visceral Sensitivity, Stress Behaviors, and Colonic Electrical Activities in Irritable Bowel Syndrome.
    Discov Med. 2023;35:805-814.
    PubMed    
    Abstract available

  54. VARRASSI G, Rekatsina M, Perrot S, Bouajina E, et al
    Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery?
    Cureus. 2023;15:e44852.
    PubMed    
    Abstract available

  55. KHAN Z, Khan SK, Reyaz I, Anam H, et al
    Effectiveness of Rifaximin on the Outcomes of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Cureus. 2023;15:e44807.
    PubMed    
    Abstract available

  56. ARNAOUT AY, Nerabani Y, Douba Z, Kassem LH, et al
    The prevalence and risk factors of irritable bowel syndrome (PRIBS study) among adults in low- and middle-income countries: A multicenter cross-sectional study.
    Health Sci Rep. 2023;6:e1592.
    PubMed    
    Abstract available

  57. BARDACKE JA, Yarrow L, Rosenkranz SK
    The Long-Term Effects of a Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet for Irritable Bowel Syndrome Management.
    Curr Dev Nutr. 2023;7:101997.
    PubMed    
    Abstract available

  58. ARORA R, Chandel AK
    Unlocking the potential of low FODMAPs sourdough technology for management of irritable bowel syndrome.
    Food Res Int. 2023;173.
    PubMed    
    Abstract available

  59. WU F, Li J, Wang JZ, Wang H, et al
    [Effects of moxibustion of "biaoben acupoint combination" on heart rate variability, atrial natriuretic peptide in the model rats of IBS-D complicated with anxiety].
    Zhongguo Zhen Jiu. 2023;43:1139-47.
    PubMed    
    Abstract available

  60. SALWEN-DEREMER JK, Bardach SH, Tormey L, Szkodny LE, et al
    Redesigning a Gastroenterology Behavioral Health Program to Improve Patient Access.
    Clin Gastroenterol Hepatol. 2023 Oct 4:S1542-3565(23)00772.
    PubMed    


  61. SJOLUND J, Kull I, Bergstrom A, Ljotsson B, et al
    Quality of life and bi-directional gut-brain interactions in irritable bowel syndrome from adolescence to adulthood.
    Clin Gastroenterol Hepatol. 2023 Oct 4:S1542-3565(23)00761.
    PubMed    
    Abstract available

  62. XIA Y, Peng S, Lin M, Duan H, et al
    Apigenin attenuates visceral hypersensitivity in water avoidance stress rats by modulating the microbiota-gut-brain axis and inhibiting mast cell activation.
    Biomed Pharmacother. 2023;167:115562.
    PubMed    
    Abstract available

  63. DROZDOV VN, Shikh EV, Astapovskii AA, Khalaidzheva KN, et al
    [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea].
    Vopr Pitan. 2023;92:92-103.
    PubMed    
    Abstract available

  64. BERLUND P, Reddington C, Cheng C, Healey M, et al
    Constipation After Elective Laparoscopy for Benign Gynecological Indications-A Prospective Observational Study.
    J Minim Invasive Gynecol. 2023;30:827-832.
    PubMed    
    Abstract available

  65. LOGANATHAN P, Herlihy D, Gajendran M, Gonzalez Z, et al
    EXPRESS: The Spectrum of Gastrointestinal Functional Bowel Disorders in Joint Hypermobility Syndrome and in an Academic Referral Center.
    J Investig Med. 2023 Oct 19:10815589231210486. doi: 10.1177/10815589231210486.
    PubMed    
    Abstract available

  66. HEYDARI R, Fayazzadeh S, Shahrokh S, Shekari F, et al
    Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2023 Oct 19:izad219. doi: 10.1093.
    PubMed    
    Abstract available

  67. BAPTIST AP, Freigeh GE, Nelson B, Carpenter L, et al
    Hereditary Angioedema in Older Adults - Understanding the Patient Perspective.
    Ann Allergy Asthma Immunol. 2023 Oct 16:S1081-1206(23)01314.
    PubMed    
    Abstract available

  68. WANG W, Wang M, Peng H, Huang J, et al
    Association of major depressive disorder and increased risk of irritable bowel syndrome: A population-based cohort study and a two-sample Mendelian randomization study in the UK biobank.
    J Affect Disord. 2023 Oct 16:S0165-0327(23)01302.
    PubMed    
    Abstract available

  69. GOMES P, Laroute V, Beaufrand C, Daveran-Mingot ML, et al
    Lactococcus lactis CNCM I-5388 versus NCDO2118 by its GABA hyperproduction ability, counteracts faster stress-induced intestinal hypersensitivity in rats.
    FASEB J. 2023;37:e23264.
    PubMed    
    Abstract available

  70. TAO E, Wu Y, Hu C, Zhu Z, et al
    Early life stress induces irritable bowel syndrome from childhood to adulthood in mice.
    Front Microbiol. 2023;14:1255525.
    PubMed    
    Abstract available

  71. ALMASARY M, Alkhalifah KM, Alotaibi SH, Elhefny M, et al
    Prevalence of Irritable Bowel Syndrome in Saudi Arabia: A Systematic Review and Meta-Analysis.
    Cureus. 2023;15:e45357.
    PubMed    
    Abstract available

  72. SARVEPALLI SS, Vemula SL, Aramadaka S, Mannam R, et al
    Digesting the Impact of Diet on Irritable Bowel Syndrome (IBS): Exploring Solutions for Controlling IBS.
    Cureus. 2023;15:e45279.
    PubMed    
    Abstract available

  73. SOUSSOU S, Jablaoui A, Mariaule V, Kriaa A, et al
    Serine proteases and metalloproteases are highly increased in irritable bowel syndrome Tunisian patients.
    Sci Rep. 2023;13:17571.
    PubMed    
    Abstract available

  74. LI Z, Li J, Fu R, Liu J, et al
    Halitosis: etiology, prevention, and the role of microbiota.
    Clin Oral Investig. 2023 Oct 16. doi: 10.1007/s00784-023-05292.
    PubMed    
    Abstract available

  75. SUN J, Ince MN, Abraham C, Barrett T, et al
    Modulating microbiome-immune axis in the deployment-related chronic diseases of Veterans: report of an expert meeting.
    Gut Microbes. 2023;15:2267180.
    PubMed    
    Abstract available

  76. COSGUN S, Polat U, Kaya M, Sezikli M, et al
    Nickel Sensitivity in Patients With Irritable Bowel Syndrome.
    Cureus. 2023;15:e45196.
    PubMed    
    Abstract available

  77. ABDULRAZAK B, Mostafa Ahmed H, Aloulou H, Mokhtari M, et al
    IoT in medical diagnosis: detecting excretory functional disorders for Older adults via bathroom activity change using unobtrusive IoT technology.
    Front Public Health. 2023;11:1161943.
    PubMed    
    Abstract available

  78. ALI MK, Gong S, Nojkov B, Burnett C, et al
    Best Parameters of Heart Rate Variability for Assessing Autonomic Responses to Brief Rectal Distention in Patients with Irritable Bowel Syndrome.
    Sensors (Basel). 2023;23:8128.
    PubMed    
    Abstract available

  79. CHIARIONI G, Popa SL, Ismaiel A, Pop C, et al
    Herbal Remedies for Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review of Randomized Controlled Trials.
    Nutrients. 2023;15:4216.
    PubMed    
    Abstract available

  80. QU Y, Park SH, Dallas DC
    Evaluating the Potential of Casein Glycomacropeptide in Adult Irritable Bowel Syndrome Management: A Pilot Study.
    Nutrients. 2023;15:4174.
    PubMed    
    Abstract available

  81. JAMSHIDI P, Farsi Y, Nariman Z, Hatamnejad MR, et al
    Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Int J Mol Sci. 2023;24:14562.
    PubMed    
    Abstract available

  82. LIU Z, Zheng Z, Wang T, Liu Z, et al
    Using ultra-performance liquid chromatography with linear ion trap-electrostatic field orbitrap mass spectrometry, network pharmacology, and molecular docking to explore the constituent targets and action mechanisms of decoction of Angelica sinensis,
    J Pharm Pharmacol. 2023 Oct 13:rgad076. doi: 10.1093.
    PubMed    
    Abstract available

  83. MALKOVICS T, Joura MI, Koszoru K, Sardy M, et al
    [Dermatitis herpetiformis and other forms of wheat sensitivity].
    Dermatologie (Heidelb). 2023 Oct 26. doi: 10.1007/s00105-023-05243.
    PubMed    
    Abstract available

  84. VORK L, Mujagic Z, Masclee AAM, Muris JWM, et al
    [Irritable bowel syndrome].
    Ned Tijdschr Geneeskd. 2023;167:D7704.
    PubMed    
    Abstract available

  85. CICIORA SL, Manickam K, Saps M
    Quality of life measures in children with Down syndrome with disorders of gut-brain interaction.
    Am J Med Genet C Semin Med Genet. 2023 Oct 26:e32071. doi: 10.1002/ajmg.c.32071.
    PubMed    
    Abstract available

  86. CHEN CY, Yu Z, Ji F, He LL, et al
    NGF/PI3K/TRPV1 pathway mediates the regulation of visceral pain by acupuncture at "Shangjuxu" (ST37) in irritable bowel syndrome rats with chronic visceral hyperalgesia.
    Zhen Ci Yan Jiu. 2023;48:1017-1024.
    PubMed    
    Abstract available

  87. SKJEVLING LK, Hanssen HM, Valle PC, Goll R, et al
    Colonic distribution of FMT by different enema procedures compared to colonoscopy - proof of concept study using contrast fluid.
    BMC Gastroenterol. 2023;23:363.
    PubMed    
    Abstract available

  88. PALANDURKAR GS, Kumar S
    Biofilm's Impact on Inflammatory Bowel Diseases.
    Cureus. 2023;15:e45510.
    PubMed    
    Abstract available

  89. YUAN C, He Y, Xie K, Feng L, et al
    Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases.
    Front Cell Infect Microbiol. 2023;13:1282431.
    PubMed    
    Abstract available

  90. PANARELLI NC
    Mast Cell Disorders of the Gastrointestinal Tract: Clarity out of Chaos.
    Surg Pathol Clin. 2023;16:755-764.
    PubMed    
    Abstract available

  91. STALLER K, Olen O, Soderling J, Roelstraete B, et al
    Antibiotic use as a risk factor for irritable bowel syndrome: Results from a nationwide, case-control study.
    Aliment Pharmacol Ther. 2023 Sep 28. doi: 10.1111/apt.17736.
    PubMed    
    Abstract available

  92. DAJTI E, Frazzoni L, Iascone V, Secco M, et al
    Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults.
    Aliment Pharmacol Ther. 2023 Oct 12. doi: 10.1111/apt.17754.
    PubMed    
    Abstract available

  93. SNIJKERS JTW, Winkens B, Weerts ZZRM, Vork L, et al
    Satisfaction with life in IBS is associated with psychological burden rather than gastrointestinal symptom severity.
    Am J Gastroenterol. 2023 Oct 4. doi: 10.14309/ajg.0000000000002547.
    PubMed    
    Abstract available

  94. KOVALEVA A, Poluektova E, Maslennikov R, Karchevskaya A, et al
    Intestinal Barrier and Gut Microbiota in Patients with Overlapping Irritable Bowel Syndrome and Functional Dyspepsia.
    Dig Dis Sci. 2023 Sep 26. doi: 10.1007/s10620-023-08117.
    PubMed    
    Abstract available

  95. JUZENAS S, Ellinghaus D, Sanna S, Franke A, et al
    Mendelian randomisation shows diverticular disease and irritable bowel syndrome increase the risk of haemorrhoidal disease.
    Gut. 2023 Oct 9:gutjnl-2023-330364. doi: 10.1136/gutjnl-2023-330364.
    PubMed    


  96. FUKUDO S, Okumura T, Inamori M, Okuyama Y, et al
    Correction: Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.
    J Gastroenterol. 2023 Sep 26. doi: 10.1007/s00535-023-02044.
    PubMed    


  97. LERARIO MP, Fusunyan M, Stave CD, Roldan V, et al
    Functional neurological disorder and functional somatic syndromes among sexual and gender minority people: A scoping review.
    J Psychosom Res. 2023 Sep 20:111491. doi: 10.1016/j.jpsychores.2023.111491.
    PubMed    
    Abstract available

  98. FORD AC, Wright-Hughes A, Alderson SL, Ow PL, et al
    Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2023 Oct 16:S0140-6736(23)01523-4. doi: 10.1016/S0140-6736(23)01523.
    PubMed    
    Abstract available

  99. DE WIT N, Keszthelyi D
    Low-dose amitriptyline in irritable bowel syndrome: ready for primary care?
    Lancet. 2023 Oct 16:S0140-6736(23)01725-7. doi: 10.1016/S0140-6736(23)01725.
    PubMed    



Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;